(VIANEWS) – Shares of SEQUANA MEDICAL (BEL 20: SEQUA.BR) jumped by a staggering 14.81% to 6.20 € at 10:25 EST on Wednesday, following the last session’s upward trend. BEL 20 is jumping 1.23% to 3,920.71 €, after three successive sessions in a row of losses. This seems, so far, an all-around up trend trading session today.
About SEQUANA MEDICAL
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of -1.25 €.
Volume
Today’s last reported volume for SEQUANA MEDICAL is 46733 which is 1157.95% above its average volume of 3715.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
SEQUANA MEDICAL’s stock is considered to be oversold (<=20).
More news about SEQUANA MEDICAL (SEQUA.BR).
